XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2018   14,015,615        
Beginning balance at Dec. 31, 2018 $ 7,824 $ 140 $ 952,626 $ (926,092) $ (20,442) $ 1,592
Comprehensive income (loss):            
Net loss (21,248)     (21,360)   112
Translation adjustments 931       970 (39)
Stock-based compensation expense 1,293   1,293      
Exercise of stock options (in shares)   5,750        
Exercise of stock options 18   18      
Vesting of restricted stock units/awards (in shares)   68,199        
Vesting of restricted stock units/awards 0 $ 1 (1)      
Vested restricted stock cancelled for employee minimum income taxes (in shares)   (20,044)        
Vested restricted stock cancelled for employee minimum income taxes (257)   (257)      
Ending balance (in shares) at Mar. 31, 2019   14,069,520.00        
Ending balance at Mar. 31, 2019 (11,439) $ 141 953,679 (947,452) (19,472) 1,665
Beginning balance (in shares) at Dec. 31, 2019   14,224,787        
Beginning balance at Dec. 31, 2019 (34,632) $ 142 956,647 (974,291) (19,318) 2,188
Comprehensive income (loss):            
Net loss (2,340)     (2,263)   (77)
Translation adjustments (2,238)       (1,781) (457)
Stock-based compensation expense 617   617      
Vesting of restricted stock units/awards (in shares)   16,089        
Vesting of restricted stock units/awards 0 $ 0 0      
Vested restricted stock cancelled for employee minimum income taxes (in shares)   (750)        
Vested restricted stock cancelled for employee minimum income taxes (10)   (10)      
Ending balance (in shares) at Mar. 31, 2020   14,240,126        
Ending balance at Mar. 31, 2020 $ (38,603) $ 142 $ 957,254 $ (976,554) $ (21,099) $ 1,654